| Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs J Salonen, L Laitinen, AM Kaukonen, J Tuura, M Björkqvist, T Heikkilä, ... Journal of controlled release 108 (2-3), 362-374, 2005 | 643 | 2005 |
| Mesoporous silicon in drug delivery applications J Salonen, AM Kaukonen, J Hirvonen, VP Lehto Journal of pharmaceutical sciences 97 (2), 632-653, 2008 | 558 | 2008 |
| Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats LM Bimbo, M Sarparanta, HA Santos, AJ Airaksinen, E Makila, ... ACS nano 4 (6), 3023-3032, 2010 | 366 | 2010 |
| Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices N Genina, J Holländer, H Jukarainen, E Mäkilä, J Salonen, N Sandler European Journal of Pharmaceutical Sciences 90, 53-63, 2016 | 323 | 2016 |
| Mesoporous silica material TUD-1 as a drug delivery system T Heikkilä, J Salonen, J Tuura, MS Hamdy, G Mul, N Kumar, T Salmi, ... International journal of pharmaceutics 331 (1), 133-138, 2007 | 290 | 2007 |
| Size, stability, and porosity of mesoporous nanoparticles characterized with light scattering M Kaasalainen, V Aseyev, E von Haartman, DŞ Karaman, E Mäkilä, ... Nanoscale research letters 12, 1-10, 2017 | 230 | 2017 |
| Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery T Heikkilä, J Salonen, J Tuura, N Kumar, T Salmi, DY Murzin, MS Hamdy, ... Drug delivery 14 (6), 337-347, 2007 | 219 | 2007 |
| The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility MA Shahbazi, M Hamidi, EM Mäkilä, H Zhang, PV Almeida, ... Biomaterials 34 (31), 7776-7789, 2013 | 216 | 2013 |
| Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods T Limnell, HA Santos, E Mäkilä, T Heikkilä, J Salonen, DY Murzin, ... Journal of pharmaceutical sciences 100 (8), 3294-3306, 2011 | 215 | 2011 |
| Fabrication and chemical surface modification of mesoporous silicon for biomedical applications J Salonen, VP Lehto Chemical Engineering Journal 137 (1), 162-172, 2008 | 204 | 2008 |
| Multistaged nanovaccines based on porous silicon@ acetalated dextran@ cancer cell membrane for cancer immunotherapy F Fontana, MA Shahbazi, D Liu, H Zhang, E Mäkilä, J Salonen, ... Advanced Materials 29 (7), 1603239, 2017 | 203 | 2017 |
| In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size HA Santos, J Riikonen, J Salonen, E Mäkilä, T Heikkilä, T Laaksonen, ... Acta biomaterialia 6 (7), 2721-2731, 2010 | 201 | 2010 |
| Drug permeation across intestinal epithelial cells using porous silicon nanoparticles LM Bimbo, E Mäkilä, T Laaksonen, VP Lehto, J Salonen, J Hirvonen, ... Biomaterials 32 (10), 2625-2633, 2011 | 187 | 2011 |
| Semimetallic TiO2 Nanotubes R Hahn, F Schmidt‐Stein, J Salonen, S Thiemann, YY Song, J Kunze, ... Angewandte Chemie International Edition 48 (39), 7236-7239, 2009 | 186 | 2009 |
| Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles T Laaksonen, H Santos, H Vihola, J Salonen, J Riikonen, T Heikkilä, ... Chemical research in toxicology 20 (12), 1913-1918, 2007 | 181 | 2007 |
| Stabilization of porous silicon surface by thermal decomposition of acetylene J Salonen, M Björkqvist, E Laine, L Niinistö Applied Surface Science 225 (1-4), 389-394, 2004 | 179 | 2004 |
| Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution M Sarparanta, LM Bimbo, J Rytkonen, E Makila, TJ Laaksonen, ... Molecular pharmaceutics 9 (3), 654-663, 2012 | 177 | 2012 |
| Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles D Liu, LM Bimbo, E Mäkilä, F Villanova, M Kaasalainen, ... Journal of Controlled Release 170 (2), 268-278, 2013 | 175 | 2013 |
| Diatom silica microparticles for sustained release and permeation enhancement following oral delivery of prednisone and mesalamine H Zhang, MA Shahbazi, EM Mäkilä, TH da Silva, RL Reis, JJ Salonen, ... Biomaterials 34 (36), 9210-9219, 2013 | 170 | 2013 |
| The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium F Araújo, N Shrestha, MA Shahbazi, P Fonte, EM Mäkilä, JJ Salonen, ... Biomaterials 35 (33), 9199-9207, 2014 | 169 | 2014 |
Hélder A. SantosUniversity Medical Center Groningen/University of Groningen在 umcg.nl 的電子郵件地址已通過驗證
